Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18032541 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy
Condition: Crohn's Disease
Interventions: Procedure: Measurement of serum infliximab and anti-infliximab antibodies;   Procedure: Treatment according to current standards without knowledge of serum infliximab and anti-infliximab Ab status

Indicates status has not been verified in more than two years